(7S,9S)-9-acetyl-7-[(2S,4S,5S,6S)-4-aziridin-1-yl-6-methyl-5-methylsulfonyloxy-oxan-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione Chemical Properties

Boiling point:

800.3±65.0 °C(Predicted)

Density 

1.59±0.1 g/cm3(Predicted)

pka

7.79±0.60(Predicted)

(7S,9S)-9-acetyl-7-[(2S,4S,5S,6S)-4-aziridin-1-yl-6-methyl-5-methylsulfonyloxy-oxan-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione Usage And Synthesis

Uses

Ladirubicin (PNU-159548) is a derivative of Daunorubicin (HY-13062A). Ladirubicin exhibits DNA intercalation and DNA alkylating properties, inhibits DNA replication and transcription, causes DNA damage, and thereby exhibits antitumor efficacy. Ladirubicin exhibits the potential to penetrate the blood-brain barrier (BBB) for its high lipophilicity. Ladirubicin exhibits toxicity through suppression of bone marrow activity[1].

References

[1] Monneret C. Recent developments in the field of antitumour anthracyclines. Eur J Med Chem. 2001 Jun;36(6):483-93. DOI:10.1016/s0223-5234(01)01244-2

(7S,9S)-9-acetyl-7-[(2S,4S,5S,6S)-4-aziridin-1-yl-6-methyl-5-methylsulfonyloxy-oxan-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione(171047-47-5)Related Product Information

• (7S,9S)-9-acetyl-7-[(2S,4S,5S,6S)-4-aziridin-1-yl-6-methyl-5-methylsulfonyloxy-oxan-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione
• N-ETHYL-TETRAHYDRO-2H-PYRAN-4-AMINE
• 1-AZIRIDINEETHANOL
• Idarubicin